Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

A Class in Session: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas

Source: A Class in Session: Understanding Current and Future Therapeutic Advances Across B-Cell Lymphomas
In this on-demand webcast, Julie M. Vose, MD, MBA; Brad S. Kahl, MD; and John P. Leonard, MD, review the current treatment paradigm for B-cell lymphomas, including key updates from ASH 2021.
Julie M. Vose, MD, MBA
Program Director
Brad S. Kahl, MD
John P. Leonard, MD
Released: February 7, 2022 Expiration: No longer available for credit
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Atara Biotherapeutics, Inc.
Bayer HealthCare Pharmaceuticals Inc.
BeiGene, Ltd.
Epizyme
Genentech, a member of the Roche Group
Genmab US, Inc.
Incyte Corporation
Karyopharm Therapeutics
Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings